Home › Stocks › XLRN

XLRN — ACCELERON PHARMA INC

Reported value held$4.30B
Funds holding (latest)34
Sector—

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q2 2026)1
Institutional value$358 · 2 sh
New / Add / Cut / Exit0 / 0 / 0 / 0 · Updated 2026-10-24
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Accumulating +0.0% (+0 sh)
Institutional value change Up +0.0%

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

As of Q2 2026, 1 SEC-registered investment managers reported holding XLRN (ACCELERON PHARMA INC) in their latest 13F filings, with a combined reported value of $358 across 2 shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +0.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Major shareholders of ACCELERON PHARMA INC (XLRN) include T. Rowe Price Associates, Vanguard Group, Farallon Capital Management, ranked by reported 13F value among the 34 institutional holders on this page.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q2 2026 1 2 $358 +0.0%
Q1 2026 1 2 $358 +0.0%
Q4 2025 1 2 $358 +0.0%
Q3 2025 1 2 $358 +0.0%
Q2 2025 1 2 $358 +0.0%
Q1 2025 1 2 $358 +0.0%
Q4 2024 1 2 $358 +0.0%
Q3 2024 1 2 $358 +0.0%

Over the 8 quarters shown, institutional share counts increased 0% in aggregate (Q3 2024 → Q2 2026).

Top Institutional Holders (Q2 2026) — 1 funds

FundSharesValuePortfolio WeightChange
HUNTINGTON NATIONAL BANK 2 $358 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q1 2026 — 1 funds

FundSharesValuePortfolio WeightChange
HUNTINGTON NATIONAL BANK 2 $358 0.00% Hold

Q4 2025 — 1 funds

FundSharesValuePortfolio WeightChange
HUNTINGTON NATIONAL BANK 2 $358 0.00% Hold

Q3 2025 — 1 funds

FundSharesValuePortfolio WeightChange
HUNTINGTON NATIONAL BANK 2 $358 0.00% Hold

Q2 2025 — 1 funds

FundSharesValuePortfolio WeightChange
HUNTINGTON NATIONAL BANK 2 $358 0.00% Hold

Q1 2025 — 1 funds

FundSharesValuePortfolio WeightChange
HUNTINGTON NATIONAL BANK 2 $358 0.00% Hold

View all 34 fund holders →

New Positions (Q2 2026)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 20 funds)

FundQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q3 2021
HUNTINGTON NATIONAL BANK 2 2 2 2 2 2 2 2 2 2 2 2 —
Northern Trust Corp — — — — — — — — — — — — 250.12K
Wells Fargo & Co — — — — — — — — — — — — 142.78K
Legal & General Investment Management America — — — — — — — — — — — — 46.45K
PNC Financial Services — — — — — — — — — — — — 6.91K
Alkeon Capital Management — — — — — — — — — — — — 1.25M
AQR Capital Management — — — — — — — — — — — — 2.36K
Balyasny Asset Management — — — — — — — — — — — — 245.49K
Bank of America Corp — — — — — — — — — — — — 282.24K
Baron Funds — — — — — — — — — — — — 1.29M
BNY Mellon — — — — — — — — — — — — 502.90K
Citigroup Inc — — — — — — — — — — — — 248.77K
D. E. Shaw & Co — — — — — — — — — — — — 271.29K
Farallon Capital Management — — — — — — — — — — — — 2.16M
Franklin Resources — — — — — — — — — — — — 399.64K
Geode Capital Management — — — — — — — — — — — — 674.64K
Invesco Ltd — — — — — — — — — — — — 408.81K
Marshall Wace — — — — — — — — — — — — 12.10K
Millennium Management — — — — — — — — — — — — 475.42K
Principal Global Investors — — — — — — — — — — — — 174.80K

Download holders (CSV)

FAQ

Which funds hold XLRN?

As of 2026-Q2, 1 institutional funds reported holding XLRN (ACCELERON PHARMA INC) in SEC 13F filings, with a combined reported value of $358.

How many shares of XLRN do institutions own?

13F filers reported 2 shares of XLRN, worth $358 in aggregate at the end of 2026-Q2.

Is institutional ownership of XLRN rising or falling?

Share counts moved +0.0% versus the prior quarter — accumulation.

Who are the top institutional holders of XLRN?

The largest 13F holders are T. Rowe Price Associates, Vanguard Group, Farallon Capital Management, Fidelity Management & Research (FMR), Janus Henderson Group; the top 25 are ranked at the top of this page.

Who are the major shareholders of ACCELERON PHARMA INC?

The major shareholders of ACCELERON PHARMA INC (XLRN) by reported 13F value are T. Rowe Price Associates, Vanguard Group, Farallon Capital Management, Fidelity Management & Research (FMR), Janus Henderson Group, among 34 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own XLRN" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/XLRN/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →